Ypsomed Holding AG Company Description

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies.

The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices.

This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics.

This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services.

It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors.

It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Ypsomed Holding AG

Country	Switzerland
Founded	1984
Industry	Medical - Equipment & Services
Sector	Healthcare
Employees	2,644
CEO	Simon Michel

Contact Details

Address: Brunnmattstrasse 6 Burgdorf, 3401 Switzerland
Phone	41 34 424 41 11
Website	ypsomed.com

Stock Details

Ticker Symbol	0QLQ
Exchange	London Stock Exchange
Fiscal Year	April - March
Reporting Currency	CHF
ISIN Number	CH0019396990
SIC Code	3842

Key Executives

Name	Position
Sebastien Delarive	Chief Executive Officer of Ypsomed Diabetes Care AG
Simon Michel	Chief Executive Officer and Member of the Board
Samuel Kunzli	Chief Financial Officer
Frank Mengis	Chief Operating Officer
Thomas Kutt	Head of Investor Relations
Dr. Nicolas Meyer	Chief Legal Officer and Secretary
Michael Zaugg	Chief Corporate Officer
Ulrike Bauer	Chief Business Officer of Ypsomed Delivery Systems